IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 269 filers reported holding IVERIC BIO INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $167,981,013 | +592.9% | 4,269,980 | +328.5% | 0.04% | +500.0% |
| Q1 2023 | $24,243,920 | -11.4% | 996,462 | -22.0% | 0.01% | -14.3% |
| Q4 2022 | $27,349,648 | +141278.4% | 1,277,424 | +18.5% | 0.01% | +40.0% |
| Q3 2022 | $19,345 | +163.6% | 1,078,298 | +41.4% | 0.01% | +150.0% |
| Q2 2022 | $7,338 | -99.9% | 762,811 | +81.3% | 0.00% | +100.0% |
| Q1 2022 | $7,080,000 | +2.4% | 420,696 | +1.7% | 0.00% | 0.0% |
| Q4 2021 | $6,914,000 | +130.8% | 413,544 | +124.2% | 0.00% | 0.0% |
| Q3 2021 | $2,996,000 | +360.2% | 184,487 | +78.7% | 0.00% | – |
| Q2 2021 | $651,000 | +21.5% | 103,245 | +18.9% | 0.00% | – |
| Q1 2021 | $536,000 | -90.3% | 86,862 | -89.1% | 0.00% | -100.0% |
| Q4 2020 | $5,510,000 | +181.4% | 797,408 | +129.7% | 0.00% | 0.0% |
| Q3 2020 | $1,958,000 | -22.6% | 347,197 | -30.0% | 0.00% | 0.0% |
| Q2 2020 | $2,531,000 | +444.3% | 496,308 | +266.9% | 0.00% | – |
| Q1 2020 | $465,000 | +132.5% | 135,268 | +479.4% | 0.00% | – |
| Q4 2019 | $200,000 | +506.1% | 23,347 | -20.5% | 0.00% | – |
| Q3 2019 | $33,000 | – | 29,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 5,339,518 | $210,056,638 | 52.85% |
| Chicago Capital Management, LLC | 359,561 | $14,145,130 | 18.12% |
| TCG Crossover Management, LLC | 2,448,829 | $96,336,933 | 15.80% |
| Vazirani Asset Management LLC | 180,000 | $7,081,200 | 11.94% |
| SYQUANT CAPITAL SAS | 406,686 | $15,999 | 11.62% |
| KRYGER CAPITAL Ltd | 2,523,853 | $99,288,377 | 10.16% |
| MPM BioImpact LLC | 1,214,662 | $47,784,803 | 9.62% |
| FNY Investment Advisers, LLC | 180,106 | $7,085 | 8.98% |
| HARVEST MANAGEMENT LLC | 213,500 | $8,399,090 | 7.25% |
| PRECEPT MANAGEMENT LLC | 130,000 | $5,114,200 | 6.94% |